Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Nuclear Medicine and Molecular Imaging|January 9, 2008
Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emissionMarleen Keyaerts, Jacob Verschueren, Tomas J Bos, et al.
Contrast Media & Molecular Imaging|August 13, 2009
Regional quantitative analysis of small animal myocardial sympathetic innervation and initial application in streptozotocin induced diabetesLode R Goethals, Caroline D Weytjens, Frank De Geeter, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2008
Comparison of the biodistribution and tumor targeting of two 99mTc-labeled anti-EGFR nanobodies in mice, using pinhole SPECT/micro-CTLea Olive Tchouate Gainkam, Lieven Huang, Vicky Caveliers, et al.
Molecular Imaging and Biology|April 13, 2010
Plasma protein binding of luciferase substrates influences sensitivity and accuracy of bioluminescence imagingMarleen Keyaerts, Carola Heneweer, Lea O Tchouate Gainkam, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 29, 2021
Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for <sup>68</sup>Ga-labelingHenri Baudhuin, Pieter-Jan Van Bockstal, Thomas De Beer, et al.
Cancers|June 26, 2019
Evaluating a Single Domain Antibody Targeting Human PD-L1 as a Nuclear Imaging and Therapeutic AgentKatrijn Broos, Quentin Lecocq, Catarina Xavier, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 13, 2021
Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint BlockadeQuentin Lecocq, Robin Maximilian Awad, Yannick De Vlaeminck, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|May 16, 2020
<sup>18</sup>F-FDG PET/CT based spleen to liver ratio associates with clinical outcome to ipilimumab in patients with metastatic melanomaAnnie Wong, Jason Callahan, Marleen Keyaerts, et al.
Pageof 7